vs
Side-by-side financial comparison of AC Immune SA (ACIU) and SAFE & GREEN HOLDINGS CORP. (OLOX). Click either name above to swap in a different company.
SAFE & GREEN HOLDINGS CORP. is the larger business by last-quarter revenue ($1.8M vs $1.4M, roughly 1.2× AC Immune SA). SAFE & GREEN HOLDINGS CORP. runs the higher net margin — -212.0% vs -1622.4%, a 1410.5% gap on every dollar of revenue. On growth, AC Immune SA posted the faster year-over-year revenue change (90.1% vs -55.8%).
AC Immune SA is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics and diagnostic solutions for neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and rare tauopathies. It operates globally, partners with leading pharmaceutical enterprises, and prioritizes addressing unmet medical needs in neurological care segments.
Safe Auto Insurance Company is an American property and casualty auto insurance carrier. It is a privately held carrier and provider of state-minimum private-passenger auto insurance for drivers in the nonstandard insurance market in 20 states across the US, including Oregon, Ohio, Indiana, Kentucky, Georgia, Pennsylvania, South Carolina, Tennessee, Louisiana, Mississippi, Illinois, Missouri, Arizona, Oklahoma, Kansas, Virginia, Texas, California, Alabama, and Colorado.
ACIU vs OLOX — Head-to-Head
Income Statement — Q2 FY2025 vs Q3 FY2024
| Metric | | |
|---|---|---|
| Revenue | $1.4M | $1.8M |
| Net Profit | $-23.3M | $-3.7M |
| Gross Margin | — | -7.2% |
| Operating Margin | -1484.5% | -127.8% |
| Net Margin | -1622.4% | -212.0% |
| Revenue YoY | 90.1% | -55.8% |
| Net Profit YoY | 6.9% | -3.0% |
| EPS (diluted) | — | $-113.82 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 25 | $1.4M | — | ||
| Q3 24 | — | $1.8M | ||
| Q2 24 | $755.7K | $1.3M | ||
| Q4 23 | — | $2.0M | ||
| Q3 23 | — | $4.0M | ||
| Q2 23 | — | $5.1M | ||
| Q1 23 | — | $5.5M | ||
| Q4 22 | — | $4.1M |
| Q2 25 | $-23.3M | — | ||
| Q3 24 | — | $-3.7M | ||
| Q2 24 | $-25.0M | $-4.7M | ||
| Q4 23 | — | $-13.6M | ||
| Q3 23 | — | $-3.6M | ||
| Q2 23 | — | $-5.6M | ||
| Q1 23 | — | $-3.5M | ||
| Q4 22 | — | $-3.7M |
| Q2 25 | — | — | ||
| Q3 24 | — | -7.2% | ||
| Q2 24 | — | 9.3% | ||
| Q4 23 | — | -101.4% | ||
| Q3 23 | — | -13.5% | ||
| Q2 23 | — | 0.7% | ||
| Q1 23 | — | -1.3% | ||
| Q4 22 | — | 3.9% |
| Q2 25 | -1484.5% | — | ||
| Q3 24 | — | -127.8% | ||
| Q2 24 | -3051.1% | -150.9% | ||
| Q4 23 | — | -536.0% | ||
| Q3 23 | — | -60.3% | ||
| Q2 23 | — | -110.1% | ||
| Q1 23 | — | -59.2% | ||
| Q4 22 | — | -93.0% |
| Q2 25 | -1622.4% | — | ||
| Q3 24 | — | -212.0% | ||
| Q2 24 | -3313.0% | -373.1% | ||
| Q4 23 | — | -695.0% | ||
| Q3 23 | — | -91.0% | ||
| Q2 23 | — | -109.0% | ||
| Q1 23 | — | -63.9% | ||
| Q4 22 | — | -91.0% |
| Q2 25 | — | — | ||
| Q3 24 | — | $-113.82 | ||
| Q2 24 | — | $-3.31 | ||
| Q4 23 | — | $-21.35 | ||
| Q3 23 | — | $-0.22 | ||
| Q2 23 | — | $-7.46 | ||
| Q1 23 | — | $-5.00 | ||
| Q4 22 | — | $-12.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $28.3M | $257.0K |
| Total DebtLower is stronger | — | $6.6M |
| Stockholders' EquityBook value | $82.2M | $-8.2M |
| Total Assets | $209.2M | $9.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 25 | $28.3M | — | ||
| Q3 24 | — | $257.0K | ||
| Q2 24 | $56.7M | $1.0M | ||
| Q4 23 | — | $14.2K | ||
| Q3 23 | — | $712.9K | ||
| Q2 23 | — | $1.6M | ||
| Q1 23 | — | $1.5M | ||
| Q4 22 | — | $582.8K |
| Q2 25 | — | — | ||
| Q3 24 | — | $6.6M | ||
| Q2 24 | — | $12.6M | ||
| Q4 23 | — | $4.1M | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | — | $3.4M |
| Q2 25 | $82.2M | — | ||
| Q3 24 | — | $-8.2M | ||
| Q2 24 | $135.8M | $-5.7M | ||
| Q4 23 | — | $-7.5M | ||
| Q3 23 | — | $5.5M | ||
| Q2 23 | — | $9.8M | ||
| Q1 23 | — | $12.8M | ||
| Q4 22 | — | $14.8M |
| Q2 25 | $209.2M | — | ||
| Q3 24 | — | $9.8M | ||
| Q2 24 | $261.3M | $20.9M | ||
| Q4 23 | — | $17.2M | ||
| Q3 23 | — | $25.3M | ||
| Q2 23 | — | $27.9M | ||
| Q1 23 | — | $28.4M | ||
| Q4 22 | — | $26.6M |
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | — | 0.23× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
